Holen Sie sich die Stockscreener-App
9.60
0.31%
-0.03
Handel nachbörslich:
9.62
0.02
+0.21%
Day One Biopharmaceuticals Inc Aktie (DAWN) Neueste Nachrichten
How The Mersana Deal Is Rewriting The Story Behind Day One Biopharmaceuticals Valuation - Yahoo Finance
Is Day One Biopharmaceuticals Inc. stock dividend yield sustainableJuly 2025 Trends & Growth Focused Stock Pick Reports - Улправда
Price-Driven Insight from (DAWN) for Rule-Based Strategy - Stock Traders Daily
Day One Biopharmaceuticals (NASDAQ:DAWN) Stock Price Down 6%What's Next? - MarketBeat
Will Day One Biopharmaceuticals Inc. stock benefit from automationWeekly Investment Summary & Smart Allocation Stock Tips - DonanımHaber
We Think Day One Biopharmaceuticals (NASDAQ:DAWN) Can Easily Afford To Drive Business Growth - Sahm
Day One Pharmaceuticals: Stock Surges Ahead Of Promising 2026I'm Bullish (NASDAQ:DAWN) - Seeking Alpha
Day One Biopharmaceuticals (NASDAQ:DAWN) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Day One Biopharmaceuticals Reports Promising FIREFLY-1 Trial Results - timothysykes.com
Day One Biopharmaceuticals (NASDAQ:DAWN) Gains Visibility Nasdaq Today - Kalkine Media
Day One Biopharmaceuticals (NASDAQ:DAWN) Trading Up 5.5%Still a Buy? - MarketBeat
Day One Biopharmaceuticals Target of Unusually Large Options Trading (NASDAQ:DAWN) - MarketBeat
Day One Biopharma (DAWN) announces positive 3-year follow-up results from pivotal phase 2 FIREFLY-1 trial of OJEMDA (tovorafenib) - MSN
Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Hudson Bay Capital Management LP Has $8.43 Million Holdings in Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Day One Biopharma (DAWN) Announces Positive 3-Year Follow-up Results from Pivotal Phase 2 FIREFLY-1 Trial of OJEMDA (Tovorafenib) - Finviz
20 Stocks That Will Double in 2026 - Insider Monkey
Braidwell LP Has $14.18 Million Position in Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Day One Biopharmaceuticals Reports Strong Q3 2025 Results - MSN
Day One Biopharmaceuticals Inc. (DAWN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Day One Biopharmaceuticals Reports Strong Q3 2025 Growth - MSN
Day One Biopharmaceuticals (NASDAQ:DAWN) Stock Price Down 4.9%What's Next? - MarketBeat
Why The Narrative Around Day One Biopharmaceuticals Is Shifting After The Mersana Acquisition - Yahoo Finance
Day One Biopharmaceuticals Expands with Mersana Acquisition - StocksToTrade
Day One Biopharmaceuticals (NASDAQ:DAWN) Sees Large Volume IncreaseTime to Buy? - MarketBeat
(DAWN) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Day One’s FIREFLY Trial Shows Promise in Pediatric Cancer Treatment - timothysykes.com
Day One Biopharmaceuticals (NASDAQ:DAWN) Nasdaq Futures Clinical-Stage Innovation - Kalkine Media
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
180,133 Shares in Day One Biopharmaceuticals, Inc. $DAWN Bought by Schroder Investment Management Group - MarketBeat
MRSN Stock Soars Over 200% Pre-Market After Day One Acquisition Deal - MSN
How buybacks impact Day One Biopharmaceuticals Inc. stock valueTrade Performance Summary & Verified High Yield Trade Plans - Newser
Day One to buy Mersana Therapeutics for $25/share upfront - MSN
Day One Biopharmaceuticals, Inc. $DAWN Shares Purchased by Geode Capital Management LLC - MarketBeat
Will Day One Biopharmaceuticals Inc. stock deliver shareholder valueJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - Newser
Day One Biopharmaceuticals, Inc. $DAWN Shares Purchased by Virtus Investment Advisers LLC - MarketBeat
Franklin Resources Inc. Purchases 79,255 Shares of Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
What drives Day One Biopharmaceuticals Inc stock pricePrice Momentum Alerts & Investor Community Interactions - earlytimes.in
(DAWN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
DAWN CEO moves Day One shares among Bender family trusts - Stock Titan
Day One Biopharmaceuticals (NASDAQ:DAWN) Trading 8% HigherStill a Buy? - MarketBeat
Day One Biopharmaceuticals stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com UK
Day One Biopharmaceuticals' (DAWN) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
How Recent Developments Are Shaping the Day One Biopharma Investment Story - Yahoo Finance
HC Wainwright & Co. Reiterates Day One Biopharmaceuticals (DAWN) Buy Recommendation - Nasdaq
DAWN: HC Wainwright & Co. Reaffirms Buy Rating with $25 Target | - GuruFocus
Buy Rating Affirmed for Day One Biopharmaceuticals: Promising FIREFLY-1 Trial Results and Ojemda’s Market Potential - TipRanks
Day One Biopharmaceuticals Announces Three-Year Results from FIREFLY-1 Trial - TradingView
Day One Announces Three Year Follow-Up Data From OJEMDA™ (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting - The Manila Times
[8-K] Day One Biopharmaceuticals, Inc. Reports Material Event | DAWN SEC FilingForm 8-K - Stock Titan
Day One Announces Three Year Follow-Up Data From OJEMDA™ - GlobeNewswire
Will Hindalco Industries Limited Stock Benefit From Industry Trends in YEARBearish Engulfing Patterns & Minimize Portfolio Damage with Warnings - earlytimes.in
Is Day One Biopharmaceuticals Inc a good long term investmentRisk Adjusted Returns & High Profit Market Tips - earlytimes.in
Day One Biopharmaceuticals unveils promising Phase 2 trial data - Traders Union
Will Day One Biopharmaceuticals Inc. stock maintain momentum in 2025Trade Analysis Report & Verified Chart Pattern Trade Signals - newser.com
0.36%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):